Deathbreak maintains a narrowly scoped product portfolio centered on its Drug application, with vulnerability reports clustering around web-page generation and input-handling weaknesses, particularly cross-site scripting. Live severity, exploitation, and exposure counts are shown alongside this summary.
The number and severity of CVEs published that impact products developed by Deathbreak over time
Signals from CVEs in this vendor scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2024-44837MEDIUM A cross-site scripting (XSS) vulnerability in the component \bean\Manager.java of Drug v1.0 allows attackers to execute arbitrary web scripts or HTML via a crafted payload injected | Sep 6, 2024 | 5.4 | 17 | NO | NO |
Signals from CVEs in this vendor scope (1 CVEs).
An overview of all social media posts that mention a CVE ID that affects a product developed by Deathbreak.
Media articles that mention a CVE ID that affects a product developed by Deathbreak — matched by CVE ID, not by vendor name.